Purchase Order 75N94021P00447

This federal contract award, with ID 75N94020P00517, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to The Regents of the University of California, San Francisco (UCSF) for a firm fixed-price purchase order valued at $90,560.00. The contract is to acquire telomere length measurements in peripheral blood samples from participants in the Diabetes Epidemiology and Clinical Research Section (DECRS) studies, in order to analyze the relationship between...

The National Institutes of Health National Heart, Lung and Blood Institute awarded a firm fixed price purchase order valued at $21,000 to Repeat Diagnostics Inc. of Ottawa, Canada. Under this contract, Repeat Diagnostics will provide telomere length measurement services using flow fluorescence in situ hybridization (flow-FISH) assay for samples from the Young Lab Members at NIH NHLBI. The work will involve testing patient samples from the lab's clinic to repeat their telomere length...

This federal contract award, valued at $12,500.00, was granted by the National Heart, Lung and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH), to Repeat Diagnostics Inc., a specialized laboratory services provider based in Ottawa, Canada. The contract is for the provision of telomere length measurement services using flow fluorescence in situ hybridization (flow-FISH) assays to support NHLBI's "YOUNG LAB" research initiative. The goal of this research...

This federal contract award is for laboratory testing services of telomere length assays provided by Repeat Diagnostics Inc. to the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH). The contract has a firm fixed price ceiling value of $4,450.00 and was awarded on December 18, 2015, with a period of performance through May 26, 2021. The contract is not associated with a set-aside designation. Repeat Diagnostics Inc. is a for-profit limited liability...

This is a $65,800 firm-fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Repeat Diagnostics Inc., a for-profit limited liability company based in Ottawa, Canada. The contract is for laboratory services to perform telomere length measurement using a 6-panel flow fluorescence in situ hybridization (flow-FISH) assay. This contract supports NCI's research into the correlation between telomere length and...

This is a $10,050.00 firm fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), to Repeat Diagnostics Inc., a specialized laboratory services provider based in Canada. The contract is for the provision of a 2-panel assay to measure telomere length using flow fluorescence in situ hybridization (flow-FISH) technology, which is a valuable diagnostic tool for NHLBI's research on disease...

The National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), awarded a $16,750.00 firm fixed-price purchase order contract to Repeat Diagnostics Inc., a specialized laboratory services provider based in Ottawa, Canada. The contract is for the provision of 2-panel assays to measure telomere length using flow fluorescence in situ hybridization (flow-FISH) technology. These services support NHLBI's biomedical research efforts, enabling clinicians to...

The National Institutes of Health National Heart Lung and Blood Institute awarded a $11,250 firm fixed price purchase order to Repeat Diagnostics Inc. to provide telomere flow fluorescence in situ hybridization testing for 45 clinical samples in support of Protocol 17-H-0121. The testing is required to continue patient care, evaluate efficacy and disease progression during the course of drug therapy under the protocol. Repeat Diagnostics will perform the testing at its laboratory located in...

The National Institute on Aging (NIA) awarded a $1.63M firm fixed-price purchase order to Quest Diagnostics Incorporated for clinical laboratory testing and assay services supporting the Healthy Aging in Neighborhoods of Diversity across the Life Span (HANDLS) study. The contract, which carries no set-aside designation, extends through July 23, 2029, with performance conducted at Quest Diagnostics' facility in Halethorpe, Maryland. The HANDLS study is a longitudinal research initiative focused...

The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $28,035 firm fixed price purchase order to Seqmatic, LLC for a SNRNASEQ study of senolytics in the aging kidney. As a small business set aside awarded under the total small business designation, Seqmatic will perform next generation sequencing services to analyze senolytic therapies that may counteract cellular senescence and related aging processes in the kidney. This contract...